Interactions of selective serotonin reuptake inhibitors with the serotonin 5-HT(2C) receptor

Psychopharmacology

Volumn 126, Issue 3, 1996, Pages 234-240

  Pälvimäki, Esa Pekka ^a   Roth, Bryan L ^b   Majasuo, Hannu ^a   Laakso, Aki ^a   Kuoppamäki, Mikko ^a   Syvälahti, Erkka ^a   Hietala, Jarmo ^c  

^a UNIVERSITY OF TURKU   (Finland)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c TURKU UNIVERSITY HOSPITAL   (Finland)

Author keywords

Antidepressants; Citalopram; Fluoxetine; Imipramine; Serotonin 5 HT(2A) receptor; Serotonin 5 HT(2C) receptor

Indexed keywords

AMITRIPTYLINE; AMOXAPINE; ANTIDEPRESSANT AGENT; CITALOPRAM; CLOMIPRAMINE; CLORGYLINE; DESIPRAMINE; DOXEPIN; DRUG METABOLITE; FLUOXETINE; IMIPRAMINE; INOSITOL PHOSPHATE; IPRINDOLE; KETANSERIN; MAPROTILINE; MESULERGINE; MIANSERIN; NOMIFENSINE; NORFLUOXETINE; NORTRIPTYLINE; RADIOLIGAND; SEROTONIN 1C RECEPTOR; SEROTONIN 2A RECEPTOR; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; SPIPERONE; TRAZODONE; TRICYCLIC ANTIDEPRESSANT AGENT; ZIMELDINE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BINDING COMPETITION; CELL CLONE; CELL LINE; CELL STRAIN 3T3; CHOROID PLEXUS; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG SELECTIVITY; HYDROLYSIS; MALE; MOUSE; NONHUMAN; PHOSPHOINOSITIDE METABOLISM; PRIORITY JOURNAL; RAT; RECEPTOR AFFINITY; RECEPTOR BINDING;

ANIMALS; ANTIDEPRESSIVE AGENTS, TRICYCLIC; CHOROID PLEXUS; CITALOPRAM; FLUOXETINE; IMIPRAMINE; MALE; PHOSPHATIDYLINOSITOLS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, SEROTONIN, 5-HT2C; RECEPTORS, SEROTONIN; SEROTONIN UPTAKE INHIBITORS;

EID: 0029975740     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02246453     Document Type: Article

References (42)

1. 2C receptor as a 60-kDa N-glycosylated protein in choroid plexus and hippocampus. J Neurochem 65:782-790
2. 1C receptors in the rat brain. J Pharmacol Exp Ther 255:843-857
3. Beasley CM, Masica DN, Potvin JH (1992) Fluoxetine: a review of receptor and functional effects and their clinical implications. Psychopharmacology 107:1-10
4. Benfield P, Heel RC, Lewis SP (1986) Fluoxetine a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in depressive illness. Drugs 32:481-508
5. Caccia S, Fracasso C, Garattini S, Guiso G, Darati S (1992) Effects of short- and long-term administration of fluoxetine on the monoamine content in rat brain. Neuropharmacology 31:343-347
6. 1C sites. Eur J Pharmacol 191:93-96
7. 3H]5-HT uptake: effect of administration of various antidepressant treatments. Neuropharmacology 32[8]:737-743
8. Conn PJ, Sanders-Bush E (1986) Agonist-induced phosphoinositide hydrolysis in choroid plexus. J Neurochem 47:1754-1760
9. Fabre LF, Crismon ML (1985) Efficacy of fluoxetine in outpatients with major depression. Curr Ther Res 37[1]:115-123
10. Fuller RW, Snoddy HD, Perry KW, Bymaster FP, Wong DT (1978) Importance of duration of drug action in the antagonism of p-chloroamphetamine depletion of brain serotonin comparison of fluoxetine and chlorimipramine. Biochem Pharmacol 27:193-198
11. Gerione RA, Codina J, Benovic JL, Lefkowitz RJ, Birnbaumer L, Caron MG (1984) The mammalian beta 2-adrenergic receptor: reconstitution of functional interactions between pure receptor and pure stimulatory nucleotide binding protein of the adenylate cyclase system. Biochemistry 23:4519-4525
12. 1-adrenergic receptor binding sites in rat tissues. Mol Pharmacol 40:531-538
13. 2C) receptors reveal novel inverse agonist activity of receptor ligands. J Biol Chem 269:11687-11690
14. 2C cell line. Brain Res 584: 191-196
15. 2 receptor characteristics in rat brain. Neurosci Lett 108:289
16. Hietala J, Koulu M, Kuoppamäki M, Lappalainen J, Syvälahti E (1992) Chronic clozapine treatment down-regulates serotonin 5-HT-1c receptors in rat brain. Prog Neuropsychopharmacol Biol Psychiatry 16:727-732
17. 1C receptor mRNA in adult rat brain. FEBS Lett 247[2]:453-462
18. 1C receptors in the antiserotonergic properties of some antidepressant drugs. Eur J Pharmacol 231:223-229
19. Karson CN, Newton JEO, Livingston R, Jolly JB, Cooper TB, Sprigg J, Komoroski RA (1993) Human brain fluoxetine concentrations. J Neuropsychiatr Clin Neurosci 5:322-329
20. 1C receptor antagonists. Eur J Pharmacol [Mol Pharmacol Sect] 245:179-182
21. 1C receptor-mediated phosphoinositide hydrolysis in the rat choroid plexus after chronic treatment with clozapine. Eur J Pharmacol 255:91-97
22. 2C receptors after chronic treatment with clozapine, chlorpromazine and three putative atypical antipsychotic drugs. Neuropsychopharmacology 13:139-151
23. 2C receptors in the rat choroid plexus. Neuropsychopharmacology (in press)
24. 2 receptors. Mol Pharmacol 42:328-335
25. 2 receptor binding sites: binding properties, brain distribution and functional role. Mol Pharmacol 21:301
26. Mann CD, Bich Vu T, Hrdina PD (1995) Protein kinase C in rat brain cortex and hippocampus: effect of repeated administration of fluoxetine and desipramine. Brit J Pharmacol 115:595-600
27. Milligan G, Bond RA, Lee M (1995) Inverse agonism: pharmacological curiosity or potential therapeutic strategy? Trends Pharmacol Sci 16:10-13
28. 1C receptor is a prominent serotonin receptor subtype in the central nervous system. Proc Natl Acad Sci USA 86[17]:6793-6797
29. Morin D, Zini R, Urien S, Tillement JP (1989) Pharmacological profile of binedaline, a new antidepressant drug. J Pharmacol Exp Ther 249[1]:288-296
30. Pazos A, Palacios JM (1985) Quantitative autoradiographic mapping of serotonin receptors in the rat brain. I. Serotonin-1 receptors. Brain Res 346:205-230
31. 2C receptors. Brain Res Mol Brain Res 23[1 2]:163-178
32. Richelson E, Pfenning M (1984) Blockade by antidepressants and related compounds of biogenic amine uptake into rat brain synaptosomes: most antidepressants selectively block norepinephrine uptake. Eur J Pharmacol 104:277-286
33. Rickels K, Amsterdam JD, Avallone MF (1986) Fluoxetine in major depression: a controlled study. Curr Ther Res 39[4]:559-563
34. 2 receptor mRNA levels. Eur J Pharmacol 207:169-172
35. 1C receptors. J Pharmacol Exp Ther 260:1361-1366
36. Sanders-Bush E, Breeding M (1988) Putative selective 5-HT-2 antagonists block 5-HT-1c receptors in the choroid plexus. J Pharmacol Exp Ther 247:169-173
37. 1C receptor reserve in choroid plexus masks receptor subsensitivity. J Pharmacol Exp Ther 252[3]:984-988
38. Sommi RW, Crismon ML, Bowden CL (1987) Fluoxetine: a serotonin-specific, second-generation antidepressant. Pharmacotherapy 7[1]:001-015
39. Torok-Both GA, Baker GB, Coutts RT, McKenna KF, Aspeslet LJ (1992) Simultaneous determination of fluoxetine and norfluoxetine enantiomers in biological samples by gas chromatography with electron-capture detection. J Chromatogr 579:99-106
40. Westphal RS, Sanders-Bush E (1994) Reciprocal binding properties of 5-hydroxytryptamine type 2C receptor agonists and inverse agonists. Mol Pharmacol 46:937-942
41. Wong DT, Threlkeld PG, Robertson DW (1991) Affinities of fluoxetine, its enantiomers, and other inhibitors of serotonin uptake for subtypes of serotonin receptors. Neuropsychopharmacology 5[1]:43-47
42. 2 receptor. Br J Pharmacol 110 [Proceedings Supplement]: 102P